Millennium Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-215,002
| Closed | -$269K | – | 7916 |
|
|
2022
Q1 | $269K | Buy |
215,002
+18,569
| +9% | +$20.2K | ﹤0.01% | 5642 |
|
|
2021
Q4 | $228K | Sell |
196,433
-180,912
| -48% | -$270K | ﹤0.01% | 5798 |
|
|
2021
Q3 | $725K | Buy |
377,345
+91,304
| +32% | +$180K | ﹤0.01% | 4991 |
|
|
2021
Q2 | $669K | Buy |
286,041
+24,185
| +9% | +$58.3K | ﹤0.01% | 5037 |
|
|
2021
Q1 | $710K | Buy |
261,856
+99,895
| +62% | +$296K | ﹤0.01% | 4526 |
|
|
2020
Q4 | $392K | Buy |
161,961
+62,472
| +63% | +$142K | ﹤0.01% | 4384 |
|
|
2020
Q3 | $228 | Buy |
99,489
+18,104
| +22% | +$47.5K | ﹤0.01% | 4006 |
|
|
2020
Q2 | $187K | Buy |
81,385
+68,664
| +540% | +$158K | ﹤0.01% | 3863 |
|
|
2020
Q1 | $22K | Sell |
12,721
-31,162
| -71% | -$63K | ﹤0.01% | 3732 |
|
|
2019
Q4 | $91K | Sell |
43,883
-72,963
| -62% | -$173K | ﹤0.01% | 4040 |
|
|
2019
Q3 | $338K | Sell |
116,846
-77,396
| -40% | -$264K | ﹤0.01% | 3496 |
|
|
2019
Q2 | $761K | Buy |
+194,242
| New | +$1.01M | ﹤0.01% | 2977 |
|
|
2019
Q1 | – | Sell |
-8,759
| Closed | -$20K | – | 4518 |
|
|
2018
Q4 | $20K | Sell |
8,759
-62,240
| -88% | -$310K | ﹤0.01% | 3668 |
|
|
2018
Q3 | $443K | Sell |
70,999
-35,674
| -33% | -$188K | ﹤0.01% | 3305 |
|
|
2018
Q2 | $730K | Buy |
+106,673
| New | +$798K | ﹤0.01% | 2996 |
|
|
2018
Q1 | – | Sell |
-15,650
| Closed | -$145K | – | 4301 |
|
|
2017
Q4 | $145K | Buy |
+15,650
| New | +$157K | ﹤0.01% | 3595 |
|
|
2017
Q2 | – | Sell |
-6,581
| Closed | -$321K | – | 4081 |
|
|
2017
Q1 | $321K | Sell |
6,581
-2,455
| -27% | -$95.9K | ﹤0.01% | 3016 |
|
|
2016
Q4 | $298K | Sell |
9,036
-3,639
| -29% | -$120K | ﹤0.01% | 2896 |
|
|
2016
Q3 | $519K | Sell |
12,675
-8,149
| -39% | -$320K | ﹤0.01% | 2587 |
|
|
2016
Q2 | $683K | Buy |
20,824
+18,222
| +700% | +$668K | ﹤0.01% | 2336 |
|
|
2016
Q1 | $161K | Sell |
2,602
-17,786
| -87% | -$565K | ﹤0.01% | 3007 |
|
|
2015
Q4 | $860K | Sell |
20,388
-64,216
| -76% | -$3.06M | ﹤0.01% | 2375 |
|
|
2015
Q3 | $4.64M | Buy |
84,604
+28,976
| +52% | +$2.87M | 0.01% | 1382 |
|
|
2015
Q2 | $6.11M | Buy |
55,628
+30,866
| +125% | +$2.87M | 0.01% | 1274 |
|
|
2015
Q1 | $2.35M | Buy |
+24,762
| New | +$1.75M | ﹤0.01% | 1855 |
|
Other funds holding GNCA
Millennium Management's GNCA Position: Q2 2022 in Review
Millennium Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 215,002 shares — an estimated $269K sold.
Millennium Management first reported a position in GNCA in Q1 2015 and held it in 25 quarters. The position peaked at $6.11M in Q2 2015. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.
- Millennium Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
- Millennium Management sold 215,002 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $269K.
- Millennium Management first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 25 quarters.
- Millennium Management's Genocea Biosciences, Inc. position peaked at $6.11M in Q2 2015.
- 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.